Metagenomi Executives Sell Shares Amid Market Volatility.

Metagenomi Therapeutics, Inc. [MGX] reports that Director and Chief Executive Officer Jian Irish has sold 1,607 shares at a price of $1.6 per share on March 5, 2026. Additionally, Chief Financial Officer Pamela Wapnick has sold 1,581 shares at the same price point, while General Counsel, Compliance Officer, and Corporate Secretary Matthew Wein has sold 482 shares at $1.6 per share on the same date.